The purpose of this study is to evaluate the safety, efficacy and accuracy of the Nasotrak System in an adult patient population.
Adults greater than 18 years of age
Able to provide informed consent or have a legally authorized representative available to provide informed consent in English
Clinically requiring a 12 Fr NG/OG tube with X-ray confirmation per standard protocol
Female subjects of childbearing age with known pregnancy or lactating.
Prisoners.
Unable to consent in English.
Subjects/ volunteers with pacemakers or life-sustaining devices in the body such as ICD.
Single group
Nasotrak System
DeviceDevice: The Nasotrak System The Nasotrak Medical System is intended to aid, in conjunction with institutional protocols, qualified operators in the placement of the Nasotrak's 12 Fr feeding tube into the stomach of patients requiring enteral feeding after insertion and before every feed. The Nasotrak nasogastric tube(NGT) is designed for use with Nasotrak's handheld device (HHD) which is able to detect the tip of the NGT via piezoelectric sensor, which converts ultrasound waves to electronic signals, thus assisting to track its location as an indicator of placement in the stomach. Nasotrak's NGT is intended only to be used with Nasotrak's HHD. The Nasotrak NGT is intended for the administration of nutrition, fluids and medications by the nasoenteric route for patients who have an intact gastrointestinal tract but are physically unable to manage nutritional intake through normal mastication and deglutition.
Evaluate the effectiveness of detecting Nasotrak's nasogastric tube's distal tip using Nasotrak's ultrasound verification algorithm compared to X-ray.
All patients will receive placement verification per institutional practice
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
